MYRIAD GENETICS INC (MYGN)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 213,100 | 195,900 | 213,300 | 211,500 |
| Cost of revenue | 61,300 | 61,700 | 63,500 | 64,400 |
| Gross profit | 151,800 | 134,200 | - | - |
| Sales and marketing expense | 71,900 | 69,200 | - | - |
| Research and development expense | 25,600 | 27,500 | 28,500 | 27,100 |
| Goodwill and long-lived asset impairment charges | 316,700 | - | 2,200 | 11,600 |
| General and administrative expense | 66,800 | 66,500 | - | - |
| Total operating expenses | 481,000 | 163,200 | - | - |
| Selling, general, and administrative expense | - | - | 139,100 | 144,900 |
| Total costs and expenses | - | - | 233,300 | 248,000 |
| Operating loss | -329,200 | -29,000 | -20,000 | -36,500 |
| Other | -100 | 100 | -800 | -300 |
| Interest income | 200 | 300 | 400 | 400 |
| Interest expense | 1,500 | 800 | 800 | 800 |
| Total other income (expense), net | -1,400 | -400 | -1,200 | -700 |
| Loss before income tax | -330,600 | -29,400 | -21,200 | -37,200 |
| Income tax benefit | -100 | -29,300 | 900 | -500 |
| Net loss | -330,500 | -100 | -22,100 | -36,700 |
| Basic (dollars per share) | -3.57 | - | -0.24 | -0.41 |
| Basic (shares) | 92,500,000 | 91,400,000 | 90,900,000 | 90,600,000 |
| Diluted (dollars per share) | -3.57 | - | -0.24 | -0.41 |
| Diluted (shares) | 92,500,000 | 91,400,000 | 90,900,000 | 90,600,000 |